Task: Answer the multiple-choice question.
Question: Which drug exhibits a -1.460\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any other words.
Options:
a.) CC(C)(C)c1ccc(OCC(O)CN(CCO)CC(O)Cn2ccc3ccccc32)cc1
b.) C/C(=N\NC(=O)c1cccnc1)c1ccc(Br)cc1
c.) Cc1ccc(N2CC(C(=O)N3CCOCC3)CC2=O)cc1Cl
d.) COc1ccccc1N1CCN(C(=O)c2coc(=O)c(Br)c2)CC1
Answer: c. Cc1ccc(N2CC(C(=O)N3CCOCC3)CC2=O)cc1Cl
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1ccc(N2CC(C(=O)N3CCOCC3)CC2=O)cc1Cl
Cc1ccc(N2CC(C(=O)N3CCOCC3)CC2=O)cc1Cl
1-(3-chloro-4-methylphenyl)-4-(morpholine-4-carbonyl)pyrrolidin-2-one